BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34515700)

  • 21. Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection.
    Dong L; Wang S; Fu B; Wang J
    Sci Rep; 2018 Nov; 8(1):9650. PubMed ID: 30504843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.
    Ohnami S; Maruyama K; Chen K; Takahashi Y; Hatakeyama K; Ohshima K; Shimoda Y; Sakai A; Kamada F; Nakatani S; Naruoka A; Ohnami S; Kusuhara M; Akiyama Y; Kagawa H; Shiomi A; Nagashima T; Urakami K; Yamaguchi K
    Mol Cell Biochem; 2021 Sep; 476(9):3469-3482. PubMed ID: 33982211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The frequency and spectrum of KRAS mutations in metastatic colorectal cancer].
    Mazurenko NN; Gagarin IM; Tsyganova IV; Mochal'nikova VV; Breder VV
    Vopr Onkol; 2013; 59(6):751-5. PubMed ID: 24624786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA.
    Wang QL; Zhou CL; Yin YF; Xiao L; Wang Y; Li K
    J Clin Lab Anal; 2020 Aug; 34(8):e23305. PubMed ID: 32207862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hot-Spot-Specific Probe (HSSP) for Rapid and Accurate Detection of KRAS Mutations in Colorectal Cancer.
    Lee HJ; Koo B; Jang YO; Liu H; Dao TNT; Lim SB; Shin Y
    Biosensors (Basel); 2022 Aug; 12(8):. PubMed ID: 36004993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of KRAS mutation in colorectal cancer patients' cfDNA with droplet digital PCR].
    Luo Y; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2018 Mar; 34(3):407-420. PubMed ID: 29577691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing.
    Jia S; Zhang R; Lin G; Peng R; Gao P; Han Y; Fu Y; Ding J; Wu Q; Zhang K; Xie J; Li J
    J Clin Lab Anal; 2018 Jun; 32(5):e22391. PubMed ID: 29380513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ; Lee SE; Kang SY; Choi YL
    Pathol Res Pract; 2011 Dec; 207(12):762-8. PubMed ID: 22070922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
    Hosoya K; Matsusaka S; Kashiwada T; Suzuki K; Ureshino N; Sato A; Miki Y; Kitera K; Hirai M; Hatake K; Kimura S; Sueoka-Aragane N
    Pathol Oncol Res; 2017 Oct; 23(4):737-744. PubMed ID: 28058585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS.
    Peng J; Wei K; Zhao X; Yang K; Wang H; Zhang Y; Guo M; He J; Wu H; Li Y; Zhao N; Huang Q; Fu W
    Mol Med Rep; 2017 Sep; 16(3):2726-2732. PubMed ID: 28677778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preclinical study of T cell receptor specifically reactive with
    Cheng XJ; Jiang D; Zhang LH; Wang JH; Li YZ; Zhai JH; Yan BQ; Zhang LL; Xie XW; Li ZY; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):884-895. PubMed ID: 36241231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification-free SERS analysis of DNA mutation in cancer cells with single-base sensitivity.
    Wu L; Garrido-Maestu A; Guerreiro JRL; Carvalho S; Abalde-Cela S; Prado M; Diéguez L
    Nanoscale; 2019 Apr; 11(16):7781-7789. PubMed ID: 30951061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer.
    Botezatu IV; Kondratova VN; Shelepov VP; Mazurenko NN; Tsyganova IV; Susova OY; Lichtenstein AV
    Anal Biochem; 2020 Feb; 590():113517. PubMed ID: 31782995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
    Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
    FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS mutations by digital PCR in circulating tumor cells isolated from the mesenteric vein are associated with residual disease and overall survival in resected colorectal cancer patients.
    Li Y; Monzo M; Moreno I; Martinez-Rodenas F; Hernandez R; Castellano JJ; Canals J; Han B; Muñoz C; Navarro A
    Int J Colorectal Dis; 2020 May; 35(5):805-813. PubMed ID: 32088737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS
    Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK
    Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.